Patent · US Active

Compounds for imaging Tau protein aggregates

US10835624B2 · kind B2 · utility

0Cited by
0References
14Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 21, 2017
Grant dateNov 17, 2020
Priority date
Expiry dateJul 21, 2037

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/2821
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to novel compounds of the formula (II) that can be employed in the selective Tau detection of disorders and abnormalities associated with Tau aggregates such as Alzheimer's disease and other tauopathies using Positron Emission Tomography (PET) Imaging.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.